Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 28;23(4):e24982.
doi: 10.2196/24982.

Clinical Effectiveness of Different Technologies for Diabetes in Pregnancy: Systematic Literature Review

Affiliations

Clinical Effectiveness of Different Technologies for Diabetes in Pregnancy: Systematic Literature Review

Claudia Eberle et al. J Med Internet Res. .

Abstract

Background: Hyperglycemia in pregnancy occurs worldwide and is closely associated with health issues in women and their offspring, such as pregnancy and birth complications, respectively, as well as comorbidities, such as metabolic and cardiovascular diseases. To optimize the management of diabetic pregnancies, sustainable strategies are urgently needed. Investigation of constantly evolving technologies for diabetes that help to manage pregnancy and health is required.

Objective: We aimed to conduct a systematic review to assess the clinical effectiveness of technologies for diabetes in pregnancy.

Methods: Relevant databases including MEDLINE (PubMed), Cochrane Library, Embase, CINAHL, and Web of Science Core Collection were searched in September 2020 for clinical studies (2008-2020). Findings were organized by type of diabetes, type of technology, and outcomes (glycemic control, pregnancy- and birth-related outcomes, and neonatal outcomes). Study quality was assessed using Effective Public Health Practice Project criteria.

Results: We identified 15 randomized controlled trials, 3 randomized crossover trials, 2 cohort studies, and 2 controlled clinical trials. Overall, 9 studies focused on type 1 diabetes, 0 studies focused on gestational diabetes, and 3 studies focused on both type 1 diabetes and type 2 diabetes. We found that 9 studies were strong quality, 11 were moderate quality, and 2 were weak quality. Technologies for diabetes seemed to have particularly positive effects on glycemic control in all types of diabetes, shown by some strong and moderate quality studies. Positive trends in pregnancy-related, birth-related, and neonatal outcomes were observed.

Conclusions: Technologies have the potential to effectively improve the management of diabetes during pregnancy. Further research on the clinical effectiveness of these technologies is needed, especially in pregnant women with type 2 diabetes.

Keywords: diabetes management; diabetes technologies; digital health; eHealth; pregnancy; systematic review.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Similar articles

Cited by

References

    1. Diabetes atlas 9th edition. International Diabetes Federation. 2019. [2021-04-19]. https://www.diabetesatlas.org/en/
    1. Chiefari E, Arcidiacono B, Foti D, Brunetti A. Gestational diabetes mellitus: an updated overview. J Endocrinol Invest. 2017 Sep;40(9):899–909. doi: 10.1007/s40618-016-0607-5. - DOI - PubMed
    1. Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care. 2007 Jul;30 Suppl 2:S141–6. doi: 10.2337/dc07-s206. - DOI - PubMed
    1. Eberle C. Fetale Programmierung des Diabetes mellitus Typ 2. MMW - Fortschritte der Medizin. 2016 Aug 13;152(S3):76–82. doi: 10.1007/bf03373173. - DOI - PubMed
    1. Eberle C, Ament C. Diabetic and metabolic programming: mechanisms altering the intrauterine milieu. ISRN Pediatr. 2012;2012:975685. doi: 10.5402/2012/975685. doi: 10.5402/2012/975685. - DOI - DOI - PMC - PubMed

Publication types